Compound ID | 3000
Diffocin
Class: Antimicrobial peptide
| Agent Type: | Natural product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against other Clostridium difficile strains |
| Description: | Natural product from Clostridium difficile; phage-derived bacteriocin/ R-type bacteriocin |
| Institute where first reported: | AvidBiotics Corporation, South San Francisco, California, USA |
| Year first mentioned: | 2012 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/jb.01272-12 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.